Literature DB >> 24395861

Association between metformin use and mortality in patients with prostate cancer: explained by confounding by indication?

Marjolein M J Zanders1, Pauline A J Vissers, Lonneke V van de Poll-Franse.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24395861     DOI： 10.1200/JCO.2013.53.5161

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  3 in total

Review 1.  Common medications and prostate cancer mortality: a review.

Authors:  Konrad H Stopsack; Alexandra J Greenberg; Lorelei A Mucci
Journal:  World J Urol       Date:  2016-08-04       Impact factor: 4.226

2.  Influence of metformin use on PSA values, free-to-total PSA, prostate cancer incidence and grade and overall survival in a prospective screening trial (ERSPC Aarau).

Authors:  Marco Randazzo; Josef Beatrice; Andreas Huber; Rainer Grobholz; Lukas Manka; Stephen F Wyler; Felix F Chun; Franz Recker; Maciej Kwiatkowski
Journal:  World J Urol       Date:  2014-10-31       Impact factor: 4.226

3.  Are metformin, statin and aspirin use still associated with overall mortality among colorectal cancer patients with diabetes if adjusted for one another?

Authors:  M M J Zanders; M P P van Herk-Sukel; P A J Vissers; R M C Herings; H R Haak; L V van de Poll-Franse
Journal:  Br J Cancer       Date:  2015-07-16       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.